Phase II Service Metrics

AbSPORU continues to drive research through our dynamic services. The information below illustrates access to our services, areas of health impacted, and the affiliations of our clients.

Note: At the end of the 2025-26 fiscal year, AbSPORU transitioned to a new client management system and a complete extract of data from the previous system was not available. Therefore some of the data illustrated below may be preliminary. Data in this report will be updated as it becomes available.

Service Requests Completed

Clients Served

Client Affiliations

Areas of Health Served

Generating Investment in Alberta-based Initiatives

Each year, AbSPORU responds to a high volume of requests for Letters of Support from researchers preparing grant applications. AbSPORU provides feedback on proposals, ensuring strategic alignment, and enhancing competitiveness.

By supporting successful grant applications for research projects with real-world impact potential, AbSPORU helps to bring new research investment into the province.

In 2025-26, grant proposals supported by AbSPORU generated:

$62.7 Million In Funding

Advancing Health Equity

In 2025-26, Equity, Diversity, Inclusion, Accessibility, and Anti-Racism (EDIAA) remained a core organizational commitment. AbSPORU continues to integrate EDIAA practices across its programs, research tools, knowledge mobilization frameworks, events, partnerships, and capacity building and training efforts to support more inclusive Patient-Oriented Research.

EDIAA Program Support

Numbers do not indicate unique/discrete projects.

Horizontal ranked chart
Order Category Bar Value Display Label
1 Addiction and/or Mental Health 59 8.5%
2 Adults (general) 21 3.0%
3 Gender-based 28 4.0%
4 Incarcerated individuals 4 0.6%
5 Indigenous People 54 7.8%
6 Maternal/Newborn 72 10.3%
7 Minority Population (other than Indigenous) 37 5.3%
8 Mobility and/or Disability 51 7.3%
9 Older/Elderly adults 37 5.3%
10 Sex-based 114 16.4%
11 Structural/Geographic vulnerability 82 11.8%
12 Youth/Pediatric 137 19.7%